Lv41
480 积分 2026-04-01 加入
Development Of RNAi Therapeutics Targeting The Complement Pathway
4个月前
已完结
Advances in oligonucleotide therapeutics: recent bench-side progress in ASO, siRNA, and aptamer
4个月前
已完结
Drug design strategies for the selective targeting of lung, liver and kidney
5个月前
已完结
Drug design strategies for the selective targeting of lung, liver and kidney
5个月前
已关闭